AHA Emerging Science™ Series

 
Welcome to Dr. Elliott Antman's AHA Emerging Science™ Series.

AHA is proud to introduce a new program to further science collaboration hosted by Dr. Elliot Antman: The AHA Emerging Science™ Series webinars are one hour professional quality webinars held three times per year. Dr. Antman will host each webinar, which will have two 30 minute blocks, consisting of presentations of original research from the following categories:

  • Late Breaking Clinical Trials
  • Clinical Trial Updates of previously presented LBCTs
  • Late Breaking Basic Science
  • Major Bench-to-Bedside Advances
  • Major Conference Proceedings
  • Major Guidelines/Policy Statements

The live webinar events will be viewable from a computer or mobile phone, both live and on-demand. Attendees can ask questions electronically during the live event or post event. View the ESS Brochure here. 

Join us at the next event, or view this blog for past events.

Latest Posts

Miss the Emerging Science Series Webinar?

The American Heart Association presents breaking Science News from the Emerging Science Series webinar, held April 24, 2013.  View the archived webinar, in addition to presentation slides, summary slides, and abstracts in Circulation.

  • Preclinical data supporting off-the-shelf bioengineered vascular grafts in hemodialysis
  • Challenges, opportunities and next steps in CVD cell-based therapies

Moderators:
Robert O. Bonow, MD, FAHA
Northwestern University Feinberg School of Medicine
Past AHA President and Chair of the Emerging Science Series Committee

Panelists:

Timothy J. Gardner, MD
Christian Care Health System
Newark, DE

Alan Nugent, MD, MBBS
UT Southwestern Medical Center
Dallas, TX

Asian Teyfik Turer, MD, MHS
UT Southwestern Medical Center
Dallas, TX

Topics:

Human Acellular Vascular Grafts: Preclinical Dataset Supports Bench-to-Bedside Transition of Tissue-Engineered Grafts for Hemodialysis Vascular Access
Presenter: Shannon L.M. Dahl, PhD,Humacyte, Inc., Durham, NC

Bringing Tissue Engineered Technologies to Clinical and Commercial Relevance in Cardiovascular Medicine
Presenter: Todd McAllister, PhD, Cytograft Tissue Engineering, Novato, CA

DISCUSS HERE

more...
Posted by PON Editor on Apr 29, 2013 9:24 AM CDT
Emerging Science Series Now Accepting Submissions


The American Heart Association has the solution through the Emerging Science Series (ESS), our live webinars which provide a year-round venue for science presentation on a fast-tracked basis.   AHA has the best science, the best education and the best opportunities for presentation.

AHA's Emerging Science Series is accepting submissions from 
February 20-March 13, 2013, 
5 p.m. CDT (UTC -06) 


Posted by PON Editor on Feb 15, 2013 11:26 AM CST
Have science that won't wait?



The American Heart Association has the solution through the Emerging Science Series (ESS), our live webinars which provide a year-round venue for science presentation on a fast-tracked basis.  Submit by Thursday, January 3rd and if your science is accepted, you will be presenting via live webinar on Wednesday, February 27th.  AHA has the best science, the best education and the best opportunities for presentation. ESS science submission opens Wednesday, December 12th!

AHA's Emerging Science Series is accepting submissions from 
Dec 12-Jan 3, 2013, 
 5 p.m. CDT (UTC -06) 

scientificsessions.org/emergingscience 

more...
Posted by PON Editor on Dec 10, 2012 2:15 PM CST
ESS 2012: New Antithrombotic Therapies - Crossing Vascular Beds and Reversing Their Effects



New Antithrombotic Therapies - Crossing Vascular Beds and Reversing Their Effects
Presented: Wednesday, June 20, 2012
more...
Posted by PON Editor on Jul 6, 2012 10:55 AM CDT
Free Webinar Today (June 20th) - Register Now!

New Antithrombotic Therapies - Crossing Vascular Beds and Reversing Their Effects

Wednesday, June 20, 2012, 12:00pm - 1:05pm CDT

REGISTER NOW

more...
Posted by PON Editor on Jun 20, 2012 8:30 AM CDT
Submit to AHA's Emerging Science™ Series!

AHA's Emerging Science™ Series is accepting submissions until May 9, 2012, 5 p.m. CDT (UTC -05).

http://scientificsessions.org/emergingscience


For learning objectives and submission guidelines, please click these links:
ESS Learning Objectives & ESS Science Submission Guidelines

more...
Posted by PON Editor on Apr 27, 2012 9:54 AM CDT
Emerging Science Series - April 25, 2012
ESS Banner

Protecting Cerebrovascular Function - From Translational Science to Clinical Trials
Wednesday, April 25, 2012, 12:00 noon - 1:05 pm

Moderators: 
  • Elliott Antman
  • Robert Harrington
  • Robert Bonow
 Panelists:
  • John Murkin
  • Jeffrey Weitz 
  • Mark Clay               

more...
Posted by PON Editor on Apr 27, 2012 9:44 AM CDT
2012 Series - Free Webinar April 25th!
ESS Banner

Protecting Cerebrovascular Function - From Translational Science to Clinical Trials
Wednesday, April 25, 2012, 12:00 noon - 1:05 pm

Button_RegisterNow_Small

Presentation Topics: 

  1. Outcomes of Discontinuing Rivaroxaban Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Analysis from the ROCKET AF Trial  
    Presenter: Jonathan P. Piccini, Duke Clinical Res Inst, Duke Univ Medical Ctr, Durham, NC
    View abstract   |   Science News Summary 
     
  2. Cerebrovascular Autoregulation Impairment is Associated with Elevations in Plasma Glial Fibrillary Acidic Protein During Congenital Heart Surgery  
    Presenter: Ronald B. Easley, Baylor Coll of Med, Houston, TX
    View manuscript   |   Science News Summary
more...
Posted by PON Editor on Apr 24, 2012 9:32 AM CDT
2011 Archive: First Human Use of an Allogeneic Tissue Engineered Vascular Graft
ESS11_Pslides_McAllister_imageFirst Human Use of an Allogeneic Tissue Engineered Vascular Graft
Description: A first-in-human study to test the feasibility of an allogeneic tissue-engineered vascular graft
Presenter: Todd N. McAllister, Novato, Calif.



 
more...
Posted by PON Editor on Mar 9, 2012 12:42 PM CST
ESS Free Webinar: Coronary and Cerebral Vascular Disease: From Clinical Trials to Systems of Care

Presentation Topics:

1) Mitral Valve Annuloplasty in Addition to Coronary Artery Bypass Grafting Improves Functional Capacity and Promotes Reverse Left Ventricular Remodelling: Preliminary Results of the Randomised Ischemic Mitral Evaluation Trial  
Presenter: K. M. John Chan, London, United Kingdom
View abstract   |   Science News Summary   

2) Relationship of National Institutes of Health Stroke Scale to 30-Day Mortality in Medicare Beneficiaries With Acute Ischemic Stroke  
Presenter: Gregg C. Fonarow, Los Angeles, Calif.
View manuscript   |   Science News Summary
more...
Posted by PON Editor on Mar 8, 2012 5:44 PM CST
< Prev    1 2   
Next >

Most Recent Comments

I am intrigued by this exciting new AHA Emerging Science Series, and particularly interested to hear the discussio...
by Alice Jacobs on More than 267 have Registered...
I am very enthusiastic to hear more about tissue engineered vascular grafts. The science is quite provocative and t...
by Frank Sellke on ESS Free Webinar On Chosen...
As the Director of the Adult Invasive and Interventional Cardiology Program in Nassau, The Bahamas, I am excited to...
by Conville Brown on ESS Free Webinar On Chosen...
I am pleased to see a translational science presentation in this first webinar of the AHA Emerging Science Series. U...
by Donna Arnett on ESS Free Webinar On Chosen...
The PLATO US substudy raises a number of important questions that will attract the attention of clinical trialists...
by Eric Bates on ESS Free Webinar On Chosen...

Login or Join

You must be logged in to comment on blogs.

Login using your My.AmericanHeart credentials:


Don't have an account?

Search Blogs